RxDoctor Payments Data

Hamilton Bice, DO

Family Medicine · Cape Charles, VANPI 1801056668

Payments from drug & device makers

$646in general payments, 2019–2025

Across 37 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$173
  • Lilly USA, LLC$76
  • Novo Nordisk$74
  • Amarin Pharma, Inc.$65
  • E.r. Squibb & Sons, L.L.C.$54
  • Pfizer$51
  • plus $154 from 6 others

What the payments were for

  • Food & beverage$646100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$646 in reported general payments places this provider in the 60th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$170,579
Medicare patients
459
Services billed
2,980

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$86,893
TrulicityDulaglutide40$48,667
JanuviaSitagliptin Phosphate43$34,421
JardianceEmpagliflozin32$29,807
OzempicSemaglutide12$21,968
TradjentaLinagliptin14$20,838
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$20,069
Breo ElliptaFluticasone/Vilanterol49$19,801
Tresiba Flextouch U-100Insulin Degludec24$18,653
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr39$18,153
XareltoRivaroxaban14$14,381
FarxigaDapagliflozin Propanediol11$12,429
MyrbetriqMirabegron25$11,783
Incruse ElliptaUmeclidinium Bromide17$6,288
Arnuity ElliptaFluticasone Furoate25$5,951

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$51$86,893110 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta$42$73,367166 claims
Boehringer IngelheimJardiance, Tradjenta$173$50,64546 claims
Lilly USA, LLCTrulicity$76$48,66740 claims
MerckJanuvia$22$34,42143 claims
Novo NordiskOzempic$74$21,96812 claims
AstraZenecaFarxiga$24$12,42911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Cape Charles

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →